XML 22 R11.htm IDEA: XBRL DOCUMENT

Fair Value Measurement

6 Months Ended

Jun. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurement

3. FAIR VALUE MEASUREMENT

The Company measures certain financial instruments at fair value in our balance sheets. The fair value of these instruments is based on valuations that include inputs that can be classified within one of the three levels of a hierarchy. Level 1 inputs include quoted market prices in an active market for identical assets or liabilities. Level 2 inputs are market data, other than Level 1, that are observable either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data. Level 3 inputs are unobservable and corroborated by little or no market data.

Except for the bond portfolio, which is required by authoritative accounting guidance to be recorded at fair value in our balance sheets, the Company elected not to record any other financial assets or liabilities at fair value on a recurring basis. We recorded an aggregate other than temporary impairment for losses on our Agape and Soul Repears bonds (Note 4), which totaled $693,000 and $658,000 for the periods ended June 30, 2020 and December 31, 2019, respectively. The following table summarizes the Company’s financial instruments that were measured at fair value on a recurring basis:

		Fair Value Measurement
June 30, 2020	Fair Value	Level 3

Bond portfolio	$17,619,937	$17,619,937

		Fair Value Measurement
December 31, 2019	Fair Value	Level 3

Bond portfolio	$16,055,937	$16,055,937

We determine the fair value of the bond portfolio shown in the table above by comparing the bonds with similar instruments in inactive markets. The analysis reflects the contractual terms of the bonds, which are callable at par by the issuer at any time, and the anticipated cash flows of the bonds and uses observable and unobservable market-based inputs. Unobservable inputs include our internal credit rating and selection of similar bonds for valuation.

The change in Level 3 assets measured at fair value on a recurring basis is summarized as follows:

	Bond Portfolio
Balance at December 31, 2019	$16,055,937
Other than temporary impairment losses on bond portfolio	(35,000)
Purchases	1,721,000
Proceeds	(122,000)
Balance at June 30, 2020	$17,619,937

Real estate held for sale and impaired loans are recorded at fair value on a nonrecurring basis. The fair value of real estate held for sale was based upon the listed sales price less expected selling costs, which is a Level 3 input. The resulting impairment charges were $0 for both periods ended June 30, 2020 and December 31, 2019, respectively.

The following table summarizes the Company’s financial instruments that were measured at fair value on a nonrecurring basis:

		June 30, 2020
		Level 1				Level 2				Level 3				Fair Value at June 30, 2020
Impaired Loans		$	—			$	—			$	5,105,245			$	5,105,245
Real estate held for resale			—				—				550,045				550,045
Totals		$	—			$	—			$	5,655,290			$	5,655,290

		December 31, 2019
		Level 1				Level 2				Level 3				Fair Value at December 31, 2019
Impaired Loans		$	—			$	—			$	4,557,326			$	4,557,326
Real estate held for resale			—				—				651,398				651,398
Totals		$	—			$	—			$	5,208,724			$	5,208,724

Loans with a carrying amount of $6,582,440 were considered impaired and written down to their fair market value of $5,105,245 as of June 30, 2020. As a result, the Company recognized a specific valuation allowance against these impaired loans totaling $1,477,194 as of June 30, 2020. Loans with a carrying amount of $5,986,813 were considered impaired and written down to their fair market value of $4,557,326 as of December 31, 2019. As a result, the Company recognized a specific valuation allowance against these impaired loans totaling $1,429,487 as of December 31, 2019.

The Company held real estate for sale which was acquired through foreclosure or via deed in lieu of foreclosure with a fair value less costs to sell of $550,045 and $651,398 for the periods ended June 30, 2020 and December 31, 2019, respectively.

		Fair Value				Valuation Technique		Significant Unobservable Inputs(s)		Range/Weighted

June 30, 2020
Impaired Loans		$	5,105,245			Market or Income Approach		Discount to Appraised Values			10-20%
Real Estate Held for Sale		$	550,045			Market or Income Approach		Discount to Appraised Values			10-20%

December 31, 2019
Impaired Loans		$	4,557,326			Market or Income Approach		Discount to Appraised Values			10-20%
Real Estate Held for Sale		$	651,398			Market or Income Approach		Discount to Appraised Values			10-20%

The fair value of impaired loans referenced above was determined by obtaining independent third-party appraisals and/or internally developed collateral valuations to support the Company’s estimates and judgments in determining the fair value of the underlying collateral supporting impaired loans.

The fair value of real estate held for resale referenced above was determined by obtaining market price valuations from independent third parties wherever such quotes were available for the other collateral owned. The Company utilized independent third party appraisals to support the Company’s estimates and judgments in determining fair value for other real estate owned.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details